2017
DOI: 10.17650/2222-8721-2017-7-1-11-29
|View full text |Cite
|
Sign up to set email alerts
|

Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials (part II)

Abstract: Активность болезниБолее 2 десятилетий назад в исследованиях на мо-делях мышей с мышечной дистрофией было показано, что ткань скелетных мышц имеет повышенный сигнал Т2 [1,2]. Аналогичные результаты получены и на мо-делях более крупных животных -собаках породы зо-лотистый ретривер с мышечной дистрофией [3][4][5]. Интересно, что сигнал Т2 от мышц нормализовывался, когда генная терапия оказывалась успешной [6][7][8].Исследования последних лет подтвердили и рас-ширили наши знания об изменении мышечного сиг-нала Т2 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 197 publications
(262 reference statements)
2
11
0
Order By: Relevance
“…Robust T 2w mapping, which is comparable to MRS as a reference standard, is essential to get an insight into the spatial distribution of acute and chronic alterations and disease activity in the muscle tissue of patients with NMD. 3,12 A robust and fat independent determination of the important biomarker T 2w is essential, especially in NMD patients, as regions with healthy muscle tissue, edematous muscle tissue, and fatty infiltrated muscle tissue are often simultaneously present in a single muscle of NMD patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Robust T 2w mapping, which is comparable to MRS as a reference standard, is essential to get an insight into the spatial distribution of acute and chronic alterations and disease activity in the muscle tissue of patients with NMD. 3,12 A robust and fat independent determination of the important biomarker T 2w is essential, especially in NMD patients, as regions with healthy muscle tissue, edematous muscle tissue, and fatty infiltrated muscle tissue are often simultaneously present in a single muscle of NMD patients.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Muscle T 2w , in contrast to muscle global T 2 , reflects the chemically selective T 2 decay of the water component in the muscle tissue and is therefore considered an indicator for water mobility in the tissue. 2,3 Water mobility in the muscle tissue is affected by several circumstances, such as inflammation, myocyte swelling, sarcoplasmic leakiness, cell necrosis, hydrostatic edema, denervation, or exercise of moderate to high intensity. 1,2 Therefore, T 2w is a rather unspecific parameter, although responding rapidly to alterations in the muscle tissue and allowing assessment of acute as well as chronic changes.…”
mentioning
confidence: 99%
“…In addition, both the relaxation and contraction states should also be taken into consideration when analyzing muscle injuries because the characteristics of muscle fibers under load are different from relaxation state [12,13]. In our study, biceps brachii was the main motor of upper limb skeletal muscle movement.…”
Section: Discussionmentioning
confidence: 94%
“…10,11 Another quantitative MRI biomarker is the water T 2 (T 2,H2O ) relaxation time, which is sensitive to changes in tissue water compartmentation, free-to-bound water ratio, and pH alterations. 1,12 An increase in T 2,H2O can be due to a range of different causes such as interstitial or cellular edema, inflammation, or necrosis, which can reflect disease activity mechanisms that precede fat replacement of skeletal muscle in neuromuscular diseases such as Duchenne muscular dystrophy (DMD). 1,7 Its sensitivity to pathophysiological changes and to the use of treatments such as corticosteroids could render T 2,H2O an interesting MRI biomarker and surrogate outcome measure in clinical studies.…”
mentioning
confidence: 99%
“…1,12 An increase in T 2,H2O can be due to a range of different causes such as interstitial or cellular edema, inflammation, or necrosis, which can reflect disease activity mechanisms that precede fat replacement of skeletal muscle in neuromuscular diseases such as Duchenne muscular dystrophy (DMD). 1,7 Its sensitivity to pathophysiological changes and to the use of treatments such as corticosteroids could render T 2,H2O an interesting MRI biomarker and surrogate outcome measure in clinical studies. 13 Elevated T 2,H2O values have been observed in muscle diseases with a known inflammatory component, such as inclusion body myositis (IBM) 2,6 and dermtomyositis, 14 in dystrophic disorders such as DMD 7,13 and facioscapulohumeral dystrophy, 14 and in myopathies where inflammation is generally absent, such as late-onset Pompe disease 4 and GNE (GNE is the gene encoding for the enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase) myopathy.…”
mentioning
confidence: 99%